Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Filovirus Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01566877
What this trial is testing

Assess the Safety, Tolerability and Pharmacokinetics of AVI-7288 in Healthy Adult Volunteers

Who this might be right for
Marburg Hemorrhagic Fever
Sarepta Therapeutics, Inc. 40
Early research (Phase 1)Study completedNCT02464670
What this trial is testing

Open-Label Study of INO-4212 With or Without INO-9012, Administered IM or ID Followed by Electroporation in Healthy Volunteers

Who this might be right for
Ebola Vaccine
Inovio Pharmaceuticals 240
Early research (Phase 1)Study completedNCT03475056
What this trial is testing

CAd3-Marburg Vaccine in Healthy Adults

Who this might be right for
Marburg Virus Disease
National Institute of Allergy and Infectious Diseases (NIAID) 40
Early research (Phase 1)WithdrawnNCT01593072
What this trial is testing

Assess the Safety, Tolerability and Pharmacokinetics of AVI-7537 in Healthy Adult Volunteers

Who this might be right for
Ebola Hemorrhagic Fever
Sarepta Therapeutics, Inc.
Early research (Phase 1)Study completedNCT06265012
What this trial is testing

Study to Evaluate the Recombinant VSV (rVSV)-Marburg Virus Vaccine Candidate (PHV01) in Healthy Adult Subjects

Who this might be right for
Marburg Virus Disease
Public Health Vaccines LLC 36
Not applicableStudy completedNCT04815174
What this trial is testing

Observational Study of the Clinico-biological Evolution and Standard of Care Offered to Patients With Ebola Virus Disease

Who this might be right for
Ebola Virus Disease
Alliance for International Medical Action 711
Testing effectiveness (Phase 2)Study completedNCT03333538
What this trial is testing

Randomized Placebo-controlled Study of Safety and Immunogenicity of GamEvac-Lyo

Who this might be right for
Healthy Volunteers
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 220
Not applicableUnknownNCT05888649
What this trial is testing

Community Preparedness for Outbreak Response and Readiness for Ebola Vaccination in Liberia

Who this might be right for
Ebola Virus Disease
UL-PIRE Africa Center 1,500
Not applicableNot Yet RecruitingNCT07688083
What this trial is testing

Clinical Validation of Isothermal Nucleic Acid Amplification Bioassays Modules - DRC

Who this might be right for
Ebola Hemorrhagic Fever
Institute of Tropical Medicine, Belgium 100
Not applicableNot Yet RecruitingNCT07821580
What this trial is testing

Study of Filovirus Disease Morbi-mortality

Who this might be right for
Filovirus Disease
Assistance Publique - Hôpitaux de Paris 10
Early research (Phase 1)Study completedNCT00374309
What this trial is testing

Experimental Vaccine for Prevention of Ebola Virus Infection

Who this might be right for
Ebola Hemorrhagic FeverEbola Virus DiseaseEbola Virus Vaccines+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 48
Not applicableStudy completedNCT02911428
What this trial is testing

Open Study of the Duration of Immunity After Vaccination With GamEvac

Who this might be right for
Hemorrhagic Fever, Ebola
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 60
Testing effectiveness (Phase 2)Study completedNCT02575456
What this trial is testing

A Clinical Trial to Evaluate the Recombinant Human Type5 Adenovirus Vector Based Ebola Virus Disease Vaccine

Who this might be right for
Ebola Disease
Jiangsu Province Centers for Disease Control and Prevention 500
Testing effectiveness (Phase 2)Study completedNCT02329054
What this trial is testing

Efficacy of Favipiravir Against Ebola (JIKI)

Who this might be right for
Ebola Virus Disease
Institut National de la Santé Et de la Recherche Médicale, France 126
Early research (Phase 1)Study completedNCT02891980
What this trial is testing

A Safety Trial to Test MVA-BN(R)-Filo and Ad26.ZEBOV Vaccines in Healthy Volunteers

Who this might be right for
Ebola DiseaseMarburg Disease
National Institute of Allergy and Infectious Diseases (NIAID) 65
Large-scale testing (Phase 3)Study completedNCT04228783
What this trial is testing

2-dose Vaccine Regimen Using 3 Consecutive Lots of Ad26.ZEBOV and MVA-BN-Filo in Adult Participants

Who this might be right for
Ebola
Janssen Vaccines & Prevention B.V. 974
Not applicableUnknownNCT06093646
What this trial is testing

Addressing Medium- to Long-term EBOLA Associated Psychological Distress and Psychosocial Problems in Central Uganda

Who this might be right for
Ebola Virus Disease
MRC/UVRI and LSHTM Uganda Research Unit 1,000
Post-approval studies (Phase 4)Study completedNCT03072030
What this trial is testing

International Multicenter Study of the Immunogenicity of Medicinal Product GamEvac-Combi

Who this might be right for
Ebola Virus DiseasePrevention
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 2,000
Early research (Phase 1)UnknownNCT04717830
What this trial is testing

An Open Study of the Safety and Pharmacokinetics of a Drug for the Emergency Prevention of Ebola Virus Disease

Who this might be right for
Ebola Virus Disease
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 25
Early research (Phase 1)Study completedNCT02495246
What this trial is testing

Assess Ebola Vaccines ChAd3-EBO-Z and Ad26.ZEBOV

Who this might be right for
Ebola Virus Disease
University of Oxford 32
Next Page